Group 1 - The core point of the news is that 乐心医疗 (Loxin Medical) experienced a decline of 5.18% in its stock price, reaching 15.19 yuan per share, with a trading volume of 115 million yuan and a turnover rate of 4.58%, resulting in a total market capitalization of 3.321 billion yuan [1] - 乐心医疗 is primarily engaged in the research, production, and sales of home medical health electronic products, with its main business revenue composition being: home medical products 66.29%, home health products 24.17%, others 7.55%, and smart wearables 1.99% [1] - The company is located in Zhongshan City, Guangdong Province, and was established on July 18, 2002, with its listing date on November 16, 2016 [1] Group 2 - From the perspective of the top ten circulating shareholders, 永赢基金 (Yongying Fund) has one fund that ranks among the top ten shareholders of 乐心医疗, while the Medical Device ETF (159883) entered the top ten circulating shareholders in the third quarter, holding 936,200 shares, which accounts for 0.58% of the circulating shares [2] - The Medical Device ETF (159883) was established on April 22, 2021, with a latest scale of 4.73 billion yuan, and has achieved a return of 11.25% this year, ranking 708 out of 5,531 in its category [2] - The fund manager of the Medical Device ETF is 储可凡 (Chu Kefa), who has a total fund asset scale of 6.282 billion yuan, with the best fund return during his tenure being 103.17% and the worst being -30.27% [3]

Group 1 - The core viewpoint of the news is that 乐心医疗 (Loxin Medical) experienced a stock price increase of 5.09%, reaching 15.27 CNY per share, with a trading volume of 1.03 billion CNY and a turnover rate of 4.23%, resulting in a total market capitalization of 33.38 billion CNY [1] - 乐心医疗 is based in Zhongshan, Guangdong Province, and was established on July 18, 2002. It was listed on November 16, 2016. The company specializes in the research, production, and sales of home healthcare electronic products, as well as the development and operation of the Loxin Smart Health Cloud platform [1] - The revenue composition of 乐心医疗 includes: 66.29% from home medical products, 24.17% from home health products, 7.55% from other sources, and 1.99% from smart wearables [1] Group 2 - From the perspective of the top ten circulating shareholders of 乐心医疗, a fund under 永赢基金 ranks among the top shareholders. The Medical Device ETF (159883) entered the top ten circulating shareholders in the third quarter, holding 936,200 shares, which accounts for 0.58% of the circulating shares, with an estimated floating profit of approximately 692,800 CNY [2] - The Medical Device ETF (159883) was established on April 22, 2021, with a current scale of 4.73 billion CNY. Year-to-date, it has achieved a return of 9.24%, ranking 717 out of 5,579 in its category; over the past year, it has returned 15.92%, ranking 3,629 out of 4,202; since inception, it has incurred a loss of 46.7% [2]